Antitrypanosomal Effect of Allopurinol: Conversion in Vivo to Aminopyrazolopyrimidine Nucleotides by Trypanosoma cruzi
- 15 September 1978
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 201 (4360) , 1018-1020
- https://doi.org/10.1126/science.356267
Abstract
The parasite Trypanosoma cruzi metabolizes allopurinol by a sequential conversion to allopurinol mononucleotide and aminopurinol mononucleotide. The latter is incorporated into RNA. This transformation of a widely used innocuous agent, allopurinol, into a toxic adenine analog appears to account for the antiprotozoan effect of allopurinol. These unique enzymatic activities appear to occur only in T. cruzi and the pathogenic lesihaminae. Allopurinol may serve as a model for the synthesis of similar antiprotozoan agents.Keywords
This publication has 8 references indexed in Scilit:
- Purine metabolism in Leishmania donovani and Leishmania braziliensisBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Antileishmanial Effect of Allopurinol. II. Relationship of Adenine Metabolism in Leishmania Species to the Action of AllopurinolThe Journal of Infectious Diseases, 1977
- A Simple Monophasic Medium for Axenic Culture of HemoflagellatesJournal of Parasitology, 1976
- Antileishmanial Effect of AllopurinolAntimicrobial Agents and Chemotherapy, 1974
- Formation of nucleotides of [6-14C]allopurinol and [6-14C]oxipurinol in rat tissues and effects on uridine nucleotide poolsBiochemical Pharmacology, 1973
- Ribonucleosides of Allopurinol and OxoallopurinolJournal of Biological Chemistry, 1967
- RIBONUCLEOSIDES OF ALLOPURINOL AND OXOALLOPURINOL - ISOLATION FROM HUMAN URINE ENZYMATIC SYNTHESIS AND CHARACTERIZATION1967